2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting ; volume:32 ; number:1 ; day:18 ; month:12 ; year:2023 ; pages:1-7 ; date:1.2024
Supportive care in cancer ; 32, Heft 1 (18.12.2023), 1-7, 1.2024
- Urheber
-
Rapoport, Bernardo Leon
Herrstedt, Jørn
Snow, Rebecca Clark
Radhakrishnan, Venkatraman
Saito, Mitsue
Navari, Rudolph M.
Smit, Teresa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-08224-1
- URN
-
urn:nbn:de:101:1-2024032721101038625555
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
12.11.2025, 14:29 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rapoport, Bernardo Leon
- Herrstedt, Jørn
- Snow, Rebecca Clark
- Radhakrishnan, Venkatraman
- Saito, Mitsue
- Navari, Rudolph M.
- Smit, Teresa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Nausea and vomiting: mechanisms and treatment
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Anticipatory nausea in cyclical vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Nausea and vomiting: mechanisms and treatment
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Anticipatory nausea in cyclical vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Nausea and vomiting: mechanisms and treatment
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Anticipatory nausea in cyclical vomiting
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study